Author:
Anderson K C, ,Kyle R A,Rajkumar S V,Stewart A K,Weber D,Richardson P
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference56 articles.
1. Anderson KC, Pazdur R, Farrell AT . Development of effective new treatments for multiple myeloma. J Clin Oncol 2005; 28: 7207–7211.
2. Anderson KC, Hannah AL, Pazdur R, Farrell AT . A strategic framework for novel drug development in multiple myeloma. Br J Haematol 2007; 138: 153–159.
3. Durie BG, Harousseau JL, Miguel JS, Blade J, Barlogie B, Anderson K et al. International uniform response criteria for multiple myeloma. Leukemia 2006; 20: 2220.
4. Blade J, Samson D, Reece D, Apperley J, Bjorkstrand B, Gahrton G et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol 1998; 102: 1115–1123.
5. Niesvizky R, Richardson PG, Rajkumar SV, Sonneveld P, Schuster MW, Coleman W et al. Quality of response with bortezomib in APEX. Hematologica 2007; 92 (Suppl. 2): 627.
Cited by
182 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献